TriMas Corporation (TRS) Stock Price & Analysis
TriMas Corporation (TRS) closed at USD 39.9 on Thursday, October 22, 2026, up 0.18% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 39.83; the Oct 22, 2026 session ranged USD 39.42–40.32 on volume of 486,519 shares. Market capitalization is $1.43B, with a 52-week range of USD 30.43–45.43 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/TRS.md
Key facts (TRS)
- Last four reported quarters (through Jun 30, 2026): revenue $768M, net income $905M (117.9% margin), free cash flow -$9.9M (SEC filings).
- Valuation: P/E 1.6x (avg 26.5x at the last 3 fiscal year-ends), EV/EBITDA 14.2x, net cash $846M.
- Earnings quality: non-operating income -$4.8M vs operating income $10.1M over the last four quarters; P/E excluding non-operating income ≈1.6x (estimate: non-operating income taxed at the company's 0% effective rate).
- 1 of 80 tracked superinvestors hold TRS (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $882K; 1 not under a Rule 10b5-1 plan ($206K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 2 Form 4 filings, $5K; 0 by opportunistic insiders, 2 by routine insiders.
- Analysts: Buy (mean 1.50 on a 1–5 scale) (2 analysts), mean target USD 45 (range 45–45).
- Total return with dividends: 1Y +1.6% vs S&P 500 +14.9%; 5Y +18.9% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 0.48, revenue estimate $175M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (TRS)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $857M | $884M | $652M | $631M | $646M | $768M |
| Gross profit | $217M | $208M | $153M | $130M | $138M | — |
| Operating income | $95.1M | $99.1M | $50.7M | $15.2M | $41.3M | $10.1M |
| Net income | $57.3M | $66.2M | $40.4M | $24.3M | $120M | $905M |
| EPS (diluted) | $1.32 | $1.56 | $0.97 | $0.60 | $2.95 | — |
| Free cash flow | $89.2M | $26.6M | $34.0M | $12.8M | $69.1M | -$9.9M |
| Gross margin | 25.3% | 23.6% | 23.5% | 20.5% | 21.4% | — |
| Operating margin | 11.1% | 11.2% | 7.8% | 2.4% | 6.4% | 1.3% |
| Net margin | 6.7% | 7.5% | 6.2% | 3.8% | 18.6% | 117.9% |
| Revenue growth | +11.3% | +3.1% | -26.2% | -3.3% | +2.4% | — |
| Cash + short-term investments | $141M | $112M | $34.9M | $23.1M | $30.0M | — |
| Total debt | $400M | $400M | $400M | $402M | $473M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (TRS)
P/E 1.6x · P/E ex non-operating (est.) ≈1.6x · P/S 1.9x · EV/EBITDA 14.2x · EV/Sales 0.8x · P/B 1.0x · FCF yield -0.69% · Earnings yield 63.24% · Dividend yield (paid, TTM) 0.44% · Buyback yield (TTM) 12.19% · Net cash $846M · EV $586M
P/E at fiscal year-ends: Dec 2025 12.0x, Dec 2024 41.3x, Dec 2023 26.2x.
Superinvestors (SEC 13F-HR, Q2 2026) (TRS)
1 of 80 tracked investors hold TRS. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.02% | $14.9M | Added +4.3% |
Insider sales (SEC Form 4, open-market, last ~7 months) (TRS)
1 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Parker Herbert K | Director | 15,000 | $675K | 20.6% | Yes (adopted March 5, 2026) | Too little history (no open-market trades in 2023) |
| 2026-05-05…2026-05-07 | Robin Jodi F. | General Counsel and Secretary | 5,000 | $206K | 12.8% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (TRS)
2 purchases, $5K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-08-12 | Tredwell Daniel P | Director | 64 | $3K | 39.63 | Routine (bought in Mar & May & Aug & Nov each year 2023–2025) |
| 2026-05-13 | Tredwell Daniel P | Director | 62 | $3K | 40.58 | Routine (bought in Mar & May & Aug & Nov each year 2023–2025) |
Analysts (TRS)
Consensus Buy (mean 1.50 on a 1–5 scale), 2 analysts; mean target USD 45 (low 45, high 45).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-03 | BWS Financial | Maintained | Buy | $45 |
Total return (dividends reinvested) (TRS)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +1.6% | +18.9% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +1.6% | +3.5% |
| Volatility (annualized) | 29.1% | 32.2% |
| Max drawdown | -22.1% (Oct 2025→Nov 2025) | -45.6% (Nov 2021→Feb 2025) |
TRS revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Packaging | $142.9M | 81.9% | -0.1% |
| Specialty Products | $31.7M | 18.1% | +10.2% |
| Total revenue | $174.6M | 100% | — |
TRS revenue by region (fiscal year ended Dec 31, 2025)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| United States | $408.0M | 63.2% | +1.3% |
| Non-US | $237.7M | 36.8% | +4.3% |
| — Europe (part of Non-US) | $150.5M | 23.3% | -5.4% |
| — Other Americas (part of Non-US) | $52.5M | 8.1% | +49.7% |
| — Asia Pacific (part of Non-US) | $34.8M | 5.4% | +2.9% |
| Total revenue | $645.7M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
TRS suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Boeing (BA) | “Our customer-specified and/or qualified products are used in the production of significant long-term aircraft programs, including most Boeing and Airbus commercial jetliner programs.” |
| Customer | Airbus | “Our customer-specified and/or qualified products are used in the production of significant long-term aircraft programs, including most Boeing and Airbus commercial jetliner programs.” |
Quoted from the company's 10-K filed Mar 2, 2026.
TRS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.48 | $0.52 | -7.1% | $175.2M | 2 |
| Next quarter (ends Dec 2026) | $0.41 | $0.43 | -2.9% | $159.7M | 2 |
| Current fiscal year (ends Dec 2026) | $1.65 | $1.67 | -1.3% | $677.7M | 2 |
| Next fiscal year (ends Dec 2027) | $2.13 | $2.17 | -1.9% | $696.6M | 2 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 39.9 |
|---|---|
| Change | ▲ 0.18% (up) |
| Previous Close | USD 39.83 |
| Open | USD 39.58 |
| Day Range | USD 39.42 – 40.32 |
| 52-Week Range | USD 30.43 – 45.43 |
| Volume | 486,519 shares |
| Market Cap | $1.43B |
| Exchange | NMS |
Technical Analysis (TRS)
Nexqual's technical model rates TRS "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 59.61 (neutral) |
| vs SMA50 | Above (USD 38.91) |
| MACD | 0.17 (positive) |
Analyst Ratings (TRS)
Wall Street analysts rate TRS "Buy" based on 2 analysts, with a mean price target of USD 45 (range USD 45–45), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 45 |
| High Target | USD 45 |
| Low Target | USD 45 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (TRS)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 0.48 |
| Revenue Estimate | $175.16M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.52 vs est 0.49 ▲ beat |
| 2026-03-31 | USD 0.24 vs est 0.19 ▲ beat |
| 2025-12-31 | USD 0.4 vs est 0.22 ▲ beat |
| 2025-09-30 | USD 0.61 vs est 0.56 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (TRS)
| Total Revenue | $664.37M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +1.60% |
| Gross Margin | +21.30% |
| Operating Margin | +7.39% |
| Profit Margin | +136.25% |
| ROE | +7.74% |
| Debt / Equity | 0.3 |
| Current Ratio | 5.44 |
| Total Cash | $1.24B |
| Total Debt | $437.77M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$9.94M (-1.3% of revenue) |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (TRS)
Nexqual rates TriMas Corporation's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Solid — Revenue +13% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 21%, operating 7% (last 12 months) |
| Balance Sheet | Strong — $1.24B cash and investments vs $397M debt (Jun 2026, SEC), net cash |
| Cash Flow | Weak — FCF negative: -$10M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Mixed — ROE 8%, ROA 1.0% |
Ownership (TRS)
| Insider Ownership | +25.09% |
|---|---|
| Institutional Ownership | +85.31% |
| Shares Outstanding | 35.87M |
| Float | 26.87M |
| Short % of Float | +16.07% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (TRS)
TriMas Corporation is led by Thomas J. Snyder, President, CEO & Director, per Nexqual as of October 23, 2026 at 09:25 UTC.
| President, CEO & Director | Thomas J. Snyder |
|---|---|
| CFO & Principal Accounting Officer | Paul A. Swart |
| Vice President of Investor Relations, Communications & Sustainability | Sherry Lauderback |
Major Backers & Investors (TRS)
Notable institutional backers of TriMas Corporation include Allspring Global Investments Holdings, LLC, Advisory Research, Inc., Permian Investment Partners, Lp, according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Allspring Global Investments Holdings, LLC | 5.31% |
| Advisory Research, Inc. | 3.38% |
| Permian Investment Partners, Lp | 3.25% |
| American Century Companies Inc | 3.21% |
| ALLSPRING FUNDS TRUST-Allspring Special Small Cap Value Fund | 2.96% |
| Jefferies Financial Group Inc. | 2.74% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 8.62% |
| BlackRock | 7.05% |
| Dimensional Fund Advisors | 6.3% |
| Geode Capital | 2.84% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
From TriMas Corporation's Latest SEC 10-K Filing (filed 2026-03-02)
Key Strengths & Strategy (as disclosed to the SEC)
- Headquartered in Bloomfield Hills, Michigan, TriMas, including our Aerospace operations, has approximately 3,700 employees who serve our customers from 37 manufacturing and support locations in 13 countries.
- Our proprietary manufacturing processes, advanced automation and specialized technical capabilities are often difficult and costly to replicate, providing a competitive advantage.
- Investments in high‑quality multi‑color printing, advanced application engineering and flexible manufacturing cells further enable us to support short lead times for high‑volume products as well as customized solutions for moderate‑volume orders.
- TriMas operates a global network of sales, manufacturing and distribution sites that enables us to efficiently serve our worldwide customer base.
Partnerships
- On November 4, 2025, we entered into the Purchase Agreement with the Purchaser to sell TriMas Aerospace.
- We have established the Strategic Investment Committee (the "Committee") to evaluate potential opportunities and other strategic uses of the funds. •Advance a One‑Company Operating Model.
Legal & Regulatory Risks (Item 1A, quoted)
- Compliance with and changes in tax laws, including tax reform legislation in the United States, could materially and adversely impact our financial condition, results of operations and cash flows.
- We may face liability associated with the use of products for which patent ownership or other intellectual property rights are claimed.
- We may be subject to claims or inquiries regarding alleged unauthorized use of a third party's intellectual property.
- We may be unable to adequately protect our intellectual property.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MYE | Myers Industries, Inc. | USD 32.83 | ▼ 0.18% |
| KRT | Karat Packaging Inc. | USD 53.84 | ▼ 1.07% |
| OI | O-I Glass, Inc. | USD 6.41 | ▲ 6.13% |
| GPK | Graphic Packaging Holding Compa | USD 9.04 | ▲ 7.75% |
| AMBP | Ardagh Metal Packaging S.A. | USD 4.73 | ▲ 3.05% |
| SLGN | Silgan Holdings Inc. | USD 39.76 | ▲ 2.05% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt